➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Moodys
McKesson
McKinsey
Merck
Medtronic

Last Updated: September 25, 2020

DrugPatentWatch Database Preview

Patent Applications for gadobenate dimeglumine

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

US Patent Applications for gadobenate dimeglumine

US Patent Application Patent No. Title Patent Filing Date Patent Application Status Status Updated
  Start Trial   Start Trial BILE ACID SALTS 2001-08-23 Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362 2014-12-08
  Start Trial   Start Trial Diagnostic imaging compositions, their methods of synthesis and use 2002-04-19 Abandoned -- Failure to Respond to an Office Action 2007-08-20
  Start Trial   Start Trial MR-SIGNAL EMITTING COATINGS 2002-05-09 Patented Case 2005-05-04
  Start Trial   Start Trial Use of heparinoid derivatives for the treatment and diagnosis of disorders which can be treated with heparinoids 2002-08-19 Abandoned -- After Examiner's Answer or Board of Appeals Decision 2008-07-17
  Start Trial   Start Trial MR-signal emitting coatings 2003-04-23 Abandoned -- Failure to Respond to an Office Action 2006-07-17
  Start Trial   Start Trial PREPARATION AND USE OF CYCLIC AND BRANCHED PEPTIDES AND THEIR LABELLED DERIVATIVES AS THERAPEUTIC AGENTS, CHOLECYSTOKININ AGONISTS OR ANTAGONISTS, AND DIAGNOSTIC AGENTS TO IDENTIFY AND LOCATE TUMOURS 2004-07-16 Patented Case 2008-01-23
  Start Trial   Start Trial Peptides conjugates, their derivatives with metal complexes and use thereof for magnetic resonance imaging (mri) 2004-09-02 Abandoned -- Failure to Respond to an Office Action 2009-03-26
>US Patent Application >Patent No. >Title >Patent Filing Date >Patent Application Status >Status Updated

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
Moodys
McKesson
AstraZeneca
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.